EBioMedicine,
Год журнала:
2021,
Номер
67, С. 103365 - 103365
Опубликована: Май 1, 2021
Cancer
remains
one
of
the
most
challenging
diseases,
as
many
patients
show
limited
therapeutic
response
to
treatment.
Liquid
biopsy
is
a
minimally
invasive
method
that
has
advantage
providing
real-time
disease
information
with
least
damage
cancer
patients.
Extracellular
vesicles
(EVs)
released
by
parental
cells
and
protected
lipid
bilayer
membrane
structure
represent
an
emerging
liquid
modality.
Apart
from
promoting
cell
growth,
proliferation,
migration,
EVs
their
cargos
(mainly
miRNAs
proteins)
are
also
biomarkers
for
diagnosis
prognosis.
Furthermore,
alterations
pre-
post-therapy
can
guide
strategy
determinations
better-stratified
therapy.
In
this
review,
we
summarize
potential
clinical
significance
in
monitoring
prediction
several
cancers
lung
cancer,
prostate
breast
melanoma,
lymphoma,
glioblastoma,
head
neck
squamous
carcinoma)
discuss
questions
require
future
investigation.
Abstract
Liquid
biopsy,
characterized
by
minimally
invasive
detection
through
biofluids
such
as
blood,
saliva,
and
urine,
has
emerged
a
revolutionary
strategy
for
cancer
diagnosis
prognosis
prediction.
Exosomes
are
subset
of
extracellular
vesicles
(EVs)
that
shuttle
molecular
cargoes
from
donor
cells
to
recipient
play
crucial
role
in
mediating
intercellular
communication.
Increasing
studies
suggest
exosomes
have
great
promise
serve
novel
biomarkers
liquid
since
large
quantities
enriched
body
fluids
involved
numerous
physiological
pathological
processes.
However,
the
further
clinical
application
been
greatly
restrained
lack
high-quality
separation
component
analysis
methods.
This
review
aims
provide
comprehensive
overview
on
conventional
technologies
exosome
isolation,
characterization
content
detection.
Additionally,
roles
serving
potential
biopsy
diagnosis,
treatment
monitoring,
prediction
summarized.
Finally,
prospects
challenges
applying
exosome-based
precision
medicine
evaluated.
Chemical Reviews,
Год журнала:
2021,
Номер
121(19), С. 12035 - 12105
Опубликована: Март 5, 2021
The
past
decade
has
witnessed
ongoing
progress
in
precision
medicine
to
improve
human
health.
As
an
emerging
diagnostic
technique,
liquid
biopsy
can
provide
real-time,
comprehensive,
dynamic
physiological
and
pathological
information
a
noninvasive
manner,
opening
new
window
for
medicine.
Liquid
depends
on
the
sensitive
reliable
detection
of
circulating
targets
(e.g.,
cells,
extracellular
vesicles,
proteins,
microRNAs)
from
body
fluids,
performance
which
is
largely
governed
by
recognition
ligands.
Aptamers
are
single-stranded
functional
oligonucleotides,
capable
folding
into
unique
tertiary
structures
bind
their
with
superior
specificity
affinity.
Their
mature
evolution
procedure,
facile
modification,
affinity
regulation,
as
well
versatile
structural
design
engineering,
make
aptamers
ideal
ligands
biopsy.
In
this
review,
we
present
broad
overview
aptamer-based
techniques
We
begin
recent
advances
aptamer
selection,
followed
summary
state-of-the-art
strategies
multivalent
assembly
interface
modification.
will
further
describe
micro-/nanoisolation
platforms,
aptamer-enabled
release
methods,
aptamer-assisted
signal
amplification
strategies.
Finally,
our
perspectives
regarding
opportunities
challenges
Frontiers in Bioengineering and Biotechnology,
Год журнала:
2022,
Номер
9
Опубликована: Янв. 5, 2022
Exosomes,
a
nano-sized
subtype
of
extracellular
vesicles
secreted
from
almost
all
living
cells,
are
capable
transferring
cell-specific
constituents
the
source
cell
to
recipient
cell.
Cumulative
evidence
has
revealed
exosomes
play
an
irreplaceable
role
in
prognostic,
diagnostic,
and
even
therapeutic
aspects.
A
method
that
can
efficiently
provide
intact
pure
samples
is
first
step
both
exosome-based
liquid
biopsies
therapeutics.
Unfortunately,
common
exosomal
separation
techniques
suffer
operation
complexity,
time
consumption,
large
sample
volumes
low
purity,
posing
significant
challenges
for
downstream
analysis.
Efficient,
simple,
affordable
methods
isolate
crucial
carrying
out
relevant
researches.
In
last
decade,
emerging
technologies,
especially
microfluidic
chips,
have
proposed
superior
strategies
exosome
isolation
exhibited
fascinating
performances.
While
many
excellent
reviews
overviewed
various
methods,
compressive
review
including
updated/improved
indispensable.
Herein,
we
overview
properties,
biogenesis,
contents,
functions.
Then,
briefly
outline
conventional
technologies
discuss
clinical
applications
these
technologies.
Finally,
large-scale
GMP
production
engineered
open
up
future
perspectives
next-generation
Exo-devices
cancer
diagnosis
treatment.
Journal of Hematology & Oncology,
Год журнала:
2022,
Номер
15(1)
Опубликована: Июнь 28, 2022
Abstract
Cancer
is
one
of
the
leading
causes
death
worldwide,
and
factors
responsible
for
its
progression
need
to
be
elucidated.
Exosomes
are
structures
with
an
average
size
100
nm
that
can
transport
proteins,
lipids,
nucleic
acids.
This
review
focuses
on
role
exosomes
in
cancer
therapy.
We
discuss
how
able
modulate
components
tumor
microenvironment
influence
proliferation
migration
rates
cells.
also
highlight
that,
depending
their
cargo,
suppress
or
promote
cell
enhance
reduce
response
radio-
chemo-therapies.
In
addition,
we
describe
trigger
chronic
inflammation
lead
immune
evasion
by
focusing
ability
transfer
non-coding
RNAs
between
cells
other
molecular
signaling
pathways
such
as
PTEN
PI3K/Akt
cancer.
Subsequently,
use
carriers
anti-tumor
agents
genetic
tools
control
progression.
then
tumor-derived
carcinogenesis.
Finally,
devote
a
section
study
diagnostic
prognostic
clinical
courses
important
treatment
patients.
provides
comprehensive
understanding
therapy,
therapeutic
value
remodeling
microenvironment.
Graphical
Journal of Hematology & Oncology,
Год журнала:
2020,
Номер
13(1)
Опубликована: Ноя. 10, 2020
Abstract
Exosomes
are
a
subset
of
extracellular
vesicles
that
carry
specific
combinations
proteins,
nucleic
acids,
metabolites,
and
lipids.
Mounting
evidence
suggests
exosomes
participate
in
intercellular
communication
act
as
important
molecular
vehicles
the
regulation
numerous
physiological
pathological
processes,
including
cancer
development.
released
by
various
cell
types
under
both
normal
conditions,
they
can
be
found
multiple
bodily
fluids.
Moreover,
carrying
wide
variety
macromolecules
provide
window
into
altered
cellular
or
tissue
states.
Their
presence
biological
fluids
renders
them
an
attractive,
minimally
invasive
approach
for
liquid
biopsies
with
potential
biomarkers
diagnosis,
prediction,
surveillance.
Due
to
their
biocompatibility
low
immunogenicity
cytotoxicity,
have
clinical
applications
development
innovative
therapeutic
approaches.
Here,
we
summarize
recent
advances
technologies
exosome
isolation
research.
We
outline
functions
regulating
tumor
metastasis,
drug
resistance,
immune
modulation
context
Finally,
discuss
prospects
challenges
exosome-based
therapeutics.
Cell Death and Disease,
Год журнала:
2020,
Номер
11(7)
Опубликована: Июль 27, 2020
Abstract
Extracellular
vesicles
(EVs)
and
particles
(EPs)
have
recently
emerged
as
active
carriers
of
molecular
biomarkers
mediators
intercellular
communication.
While
most
investigations
focused
exclusively
on
the
protein,
lipid
RNA
constituents
these
extracellular
entities,
EV/EP
DNA
remains
poorly
understood,
despite
being
found
in
association
with
virtually
all
populations.
The
functional
potential
has
been
proposed
a
number
pathological
states,
including
malignancies
autoimmune
diseases.
Moreover,
effectiveness
cell-free
biomarker
choice
emerging
liquid
biopsy
applications
highlights
role
that
may
play
novel
disease
biomarker.
In
this
review,
we
provide
comprehensive
overview
studies
conducted
to
date,
particular
focus
roles
mediator
various
pathologic
states.
We
also
review
what
is
currently
known
about
origins,
structure,
localisation
distribution
DNA,
highlighting
current
controversies
well
opportunities
for
future
investigation.
Abstract
Colorectal
cancer
(CRC)
is
one
of
the
most
common
cancers
worldwide
and
a
leading
cause
carcinogenic
death.
To
date,
surgical
resection
regarded
as
gold
standard
by
operator
for
clinical
decisions.
Because
conventional
tissue
biopsy
invasive
only
small
sample
can
sometimes
be
obtained,
it
unable
to
represent
heterogeneity
tumor
or
dynamically
monitor
progression.
Therefore,
there
an
urgent
need
find
new
minimally
noninvasive
diagnostic
strategy
detect
CRC
at
early
stage
recurrence.
Over
past
years,
concept
called
“liquid
biopsy”
has
gained
much
attention.
Liquid
noninvasive,
allowing
repeated
analysis
real-time
monitoring
recurrence,
metastasis
therapeutic
responses.
With
advanced
development
molecular
techniques
in
CRC,
circulating
cells
(CTCs),
DNA
(ctDNA),
exosomes,
tumor-educated
platelet
(TEP)
detection
have
achieved
interesting
inspiring
results
prominent
liquid
markers.
In
this
review,
we
focused
on
some
applications
CTCs,
ctDNA,
exosomes
TEPs
discuss
promising
future
solve
unmet
needs
patients.
ACS Biomaterials Science & Engineering,
Год журнала:
2023,
Номер
9(2), С. 577 - 594
Опубликована: Янв. 9, 2023
Exosomes
are
the
phospholipid-membrane-bound
subpopulation
of
extracellular
vesicles
derived
from
plasma
membrane.
The
main
activity
exosomes
is
cellular
communication.
In
cancer,
play
an
important
rolefrom
two
distinct
perspectives,
one
related
to
carcinogenesis
and
other
as
theragnostic
drug
delivery
tools.
outer
phospholipid
membrane
Exosome
improves
targeting
efficiency.
.
Some
vital
features
such
biocompatibility,
low
toxicity,
immunogenicity
make
it
a
more
exciting
system.
Exosome-based
new
innovative
approach
cancer
treatment.
Exosome-associated
biomarker
analysis
heralded
era
diagnostics
in
specific
way.
This
Review
focuses
on
exosome
biogenesis,
sources,
isolation,
interrelationship
with
exosome-related
biomarkers,
loading
methods,
exosome-based
biomolecule
delivery,
advances
limitations
clinical
settings
studies.
understanding
will
change
diagnostic
therapeutic
future.
Liquid
biopsy
offers
non-invasive
and
real-time
molecular
profiling
of
individual
patients,
is
thus
considered
a
revolutionary
technology
in
precision
medicine.
Exosomes
have
been
acknowledged
as
significant
biomarkers
liquid
biopsy,
they
play
central
role
cell-cell
communication
are
closely
related
to
the
pathogenesis
most
human
malignancies.
Nevertheless,
biofluids
exosomes
always
co-exist
with
other
particles,
cargo
components
highly
heterogeneous.
Thus,
isolation
characterization
still
technically
challenging.
Microfluidics
effectively
addresses
this
challenge
by
virtue
its
inherent
advantages,
such
precise
manipulation
fluids,
low
consumption
samples
reagents,
high
level
integration.
Recent
advances
microfluidics
allow
situ
exosome
capture
detection
unprecedented
selectivity
sensitivity.
In
review,
state-of-the-art
developments
microfluidics-based
research,
including
approaches
strategies,
highlights
exosomal
cancer
summarized.
The
major
challenges
also
discussed
some
perspectives
for
future
directions
exosome-based
microfluidic
systems
presented.